HOME › DRUGS › LATANOPROST
ACTIVE SUBSTANCE / INN

LATANOPROST

Brand name(s): IYUZEH, XELPROS, Catiolanze, ROCKLATAN, LATANOPROST, XALATAN
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
NDA206185
ANDA201786
ACTIVE SUBSTANCE
Latanoprost
REGULATORS
FDA · EMA
SPONSORS / MAH
ALCON LABS INC, SOMERSET, Santen Oy
TOTAL APPLICATIONS
8
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LATANOPROSTANDA201786SOMERSETPrescription
LATANOPROSTANDA202077CARNEGIEDiscontinued
XELPROSNDA206185SUN PHARMDiscontinued
IYUZEHNDA216472THEA PHARMAPrescription
XALATANNDA020597UPJOHNPrescription
ROCKLATANNDA208259ALCON LABS INCPrescription
LATANOPROSTANDA076218PAR PHARMNone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
CatiolanzeSanten OyAuthorised15/11/2023Glaucoma, Open-Angle

FULL INTELLIGENCE ON LATANOPROST

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →